BLLN - CIK 0002070849
BillionToOne, Inc. trades as BLLN and has a market capitalization of $4.51 B, making it the #1478 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $305.11M, up 100.0% from the prior year and net income of $7.45M. This page tracks BillionToOne, Inc. through 61 SEC filings, with financial statements and metrics updated as new reports are filed.
Net profit margin expanded from -115.3% to 2.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| Annual report to shareholders | ARS | 2026-04-21 |
| Proxy materials | DEFA14A | 2026-04-21 |
| Proxy statement | DEF 14A | 2026-04-21 |
| Annual report | 10-K | 2026-03-11 |
May 06, 2026 16:05 ET
Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests ...
April 15, 2026 08:05 ET | Source: BillionToOne, Inc. BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026. MENLO PARK ...
The largest companies sharing BillionToOne, Inc.'s SEC industry classification (services-medical laboratories).
BillionToOne, Inc. (BLLN) has a market capitalization of $4.51 B as of 2026-05-29, ranking #1478 among US-listed companies.
BillionToOne, Inc. reported revenue of $305.11M for fiscal year 2025, an increase of 100.0% year over year.
Yes. BillionToOne, Inc. reported net income of $7.45M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.